Actavis CEO Says Health Law May Boost Generics Use

Feb. 15 (Bloomberg) -- Paul Bisaro, chief executive officer of Actavis Inc., talks about the impact of the U.S. Affordable Care Act on the pharmaceutical industry, so-called biosimilars, generic versions of biotechnology drugs, and the outlook for growth. He speaks with Mark Crumpton on Bloomberg Television's "Bottom Line." (Source: Bloomberg)
Convenient for Schaeuble to Believe in Greece: Calomiris
55:40 - March 2 -- Henry Kaufman Professor of Financial Institutions Charles Calomiris talks about the politics behind Greece’s debt negotiations with the European Union. He speaks on “Bloomberg Surveillance.”
  • `The Whites’: Charlie Rose 03/02
  • Cisco CEO John Chambers: Charlie Rose 03/02
  • Senator Lindsey Graham: Charlie Rose 03/02